• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症中局部突变过程的序列依赖性和突变率。

Sequence dependencies and mutation rates of localized mutational processes in cancer.

机构信息

Department of Clinical Medicine, Aarhus University, Palle Juul-Jensens Boulevard 82, 8200, Aarhus N, Denmark.

Department of Molecular Medicine (MOMA), Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200, Aarhus N, Denmark.

出版信息

Genome Med. 2023 Aug 17;15(1):63. doi: 10.1186/s13073-023-01217-z.

DOI:10.1186/s13073-023-01217-z
PMID:37592287
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10436389/
Abstract

BACKGROUND

Cancer mutations accumulate through replication errors and DNA damage coupled with incomplete repair. Individual mutational processes often show nucleotide sequence and functional region preferences. As a result, some sequence contexts mutate at much higher rates than others, with additional variation found between functional regions. Mutational hotspots, with recurrent mutations across cancer samples, represent genomic positions with elevated mutation rates, often caused by highly localized mutational processes.

METHODS

We count the 11-mer genomic sequences across the genome, and using the PCAWG set of 2583 pan-cancer whole genomes, we associate 11-mers with mutational signatures, hotspots of single nucleotide variants, and specific genomic regions. We evaluate the mutation rates of individual and combined sets of 11-mers and derive mutational sequence motifs.

RESULTS

We show that hotspots generally identify highly mutable sequence contexts. Using these, we show that some mutational signatures are enriched in hotspot sequence contexts, corresponding to well-defined sequence preferences for the underlying localized mutational processes. This includes signature 17b (of unknown etiology) and signatures 62 (POLE deficiency), 7a (UV), and 72 (linked to lymphomas). In some cases, the mutation rate and sequence preference increase further when focusing on certain genomic regions, such as signature 62 in transcribed regions, where the mutation rate is increased up to 9-folds over cancer type and mutational signature average.

CONCLUSIONS

We summarize our findings in a catalog of localized mutational processes, their sequence preferences, and their estimated mutation rates.

摘要

背景

癌症突变是通过复制错误和 DNA 损伤以及不完全修复而积累的。个体突变过程通常表现出核苷酸序列和功能区域的偏好。因此,一些序列背景的突变率比其他序列背景高得多,在功能区域之间还存在额外的变化。突变热点是指在癌症样本中经常出现的反复突变的基因组位置,代表了突变率升高的基因组位置,通常是由高度局部化的突变过程引起的。

方法

我们在整个基因组上计算 11-mer 基因组序列,并使用 PCAWG 中的 2583 个泛癌症全基因组,将 11-mer 与突变特征、单核苷酸变异热点和特定基因组区域相关联。我们评估了单个和组合的 11- mer 的突变率,并推导出突变序列基序。

结果

我们表明热点通常可以识别高度易变的序列背景。利用这些热点,我们表明一些突变特征在热点序列背景中富集,对应于潜在局部突变过程的明确序列偏好。这包括特征 17b(病因不明)和特征 62(POLE 缺陷)、7a(UV)和 72(与淋巴瘤相关)。在某些情况下,当关注某些基因组区域时,突变率和序列偏好会进一步增加,例如特征 62 在转录区域,突变率比癌症类型和突变特征平均高出 9 倍。

结论

我们将发现总结在本地化突变过程、其序列偏好及其估计的突变率目录中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b68a/10436389/bec886758125/13073_2023_1217_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b68a/10436389/8065dfea1d17/13073_2023_1217_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b68a/10436389/a572317750ad/13073_2023_1217_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b68a/10436389/27b01ef45223/13073_2023_1217_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b68a/10436389/93e2067c2d24/13073_2023_1217_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b68a/10436389/7963fab0f3c6/13073_2023_1217_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b68a/10436389/bec886758125/13073_2023_1217_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b68a/10436389/8065dfea1d17/13073_2023_1217_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b68a/10436389/a572317750ad/13073_2023_1217_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b68a/10436389/27b01ef45223/13073_2023_1217_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b68a/10436389/93e2067c2d24/13073_2023_1217_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b68a/10436389/7963fab0f3c6/13073_2023_1217_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b68a/10436389/bec886758125/13073_2023_1217_Fig6_HTML.jpg

相似文献

1
Sequence dependencies and mutation rates of localized mutational processes in cancer.癌症中局部突变过程的序列依赖性和突变率。
Genome Med. 2023 Aug 17;15(1):63. doi: 10.1186/s13073-023-01217-z.
2
Hotspot mutations delineating diverse mutational signatures and biological utilities across cancer types.热点突变描绘了不同癌症类型中多样的突变特征和生物学功能。
BMC Genomics. 2016 Jun 23;17 Suppl 2(Suppl 2):394. doi: 10.1186/s12864-016-2727-x.
3
Hotspot propensity across mutational processes.热点突变倾向于多种突变过程。
Mol Syst Biol. 2024 Jan;20(1):6-27. doi: 10.1038/s44320-023-00001-w. Epub 2023 Dec 20.
4
Regional mutational signature activities in cancer genomes.癌症基因组中的区域突变特征活动。
PLoS Comput Biol. 2022 Dec 5;18(12):e1010733. doi: 10.1371/journal.pcbi.1010733. eCollection 2022 Dec.
5
The repertoire of mutational signatures in human cancer.人类癌症中的突变特征谱。
Nature. 2020 Feb;578(7793):94-101. doi: 10.1038/s41586-020-1943-3. Epub 2020 Feb 5.
6
Analysis of mutational signatures in C. elegans: Implications for cancer genome analysis.秀丽隐杆线虫突变特征分析:对癌症基因组分析的启示。
DNA Repair (Amst). 2020 Nov;95:102957. doi: 10.1016/j.dnarep.2020.102957. Epub 2020 Aug 28.
7
Functional and genetic determinants of mutation rate variability in regulatory elements of cancer genomes.癌症基因组调控元件突变率可变性的功能和遗传决定因素。
Genome Biol. 2021 May 3;22(1):133. doi: 10.1186/s13059-021-02318-x.
8
Nuclear topology modulates the mutational landscapes of cancer genomes.核拓扑结构调节癌症基因组的突变图谱。
Nat Struct Mol Biol. 2017 Nov;24(11):1000-1006. doi: 10.1038/nsmb.3474. Epub 2017 Oct 2.
9
Mutational signatures and mutable motifs in cancer genomes.癌症基因组中的突变特征和可突变基序。
Brief Bioinform. 2018 Nov 27;19(6):1085-1101. doi: 10.1093/bib/bbx049.
10
An analysis of mutational signatures of synonymous mutations across 15 cancer types.分析 15 种癌症中同义突变的突变特征。
BMC Med Genet. 2019 Dec 9;20(Suppl 2):190. doi: 10.1186/s12881-019-0926-4.

引用本文的文献

1
MAFcounter: an efficient tool for counting the occurrences of k-mers in MAF files.MAFcounter:一种用于统计MAF文件中k-mer出现次数的高效工具。
BMC Bioinformatics. 2025 May 30;26(1):142. doi: 10.1186/s12859-025-06172-7.
2
A prognostic model for laryngeal squamous cell carcinoma based on the mitochondrial metabolism-related genes.基于线粒体代谢相关基因的喉鳞状细胞癌预后模型
Transl Cancer Res. 2025 Feb 28;14(2):966-979. doi: 10.21037/tcr-24-1436. Epub 2025 Feb 18.
3
MAFcounter: An efficient tool for counting the occurrences of k-mers in MAF files.

本文引用的文献

1
Mutational signatures: emerging concepts, caveats and clinical applications.突变特征:新兴概念、注意事项与临床应用
Nat Rev Cancer. 2021 Oct;21(10):619-637. doi: 10.1038/s41568-021-00377-7. Epub 2021 Jul 27.
2
The landscape and driver potential of site-specific hotspots across cancer genomes.癌症基因组中位点特异性热点的格局及驱动潜力。
NPJ Genom Med. 2021 May 13;6(1):33. doi: 10.1038/s41525-021-00197-6.
3
Functional and genetic determinants of mutation rate variability in regulatory elements of cancer genomes.癌症基因组调控元件突变率可变性的功能和遗传决定因素。
MAFcounter:一种用于统计MAF文件中k-mer出现次数的高效工具。
ArXiv. 2024 Nov 29:arXiv:2411.19427v1.
4
Target-Enhanced Whole-Genome Sequencing Shows Clinical Validity Equivalent to Commercially Available Targeted Oncology Panel.靶向增强全基因组测序显示临床有效性等同于市售的肿瘤靶向检测试剂盒。
Cancer Res Treat. 2025 Apr;57(2):350-361. doi: 10.4143/crt.2024.114. Epub 2024 Sep 19.
5
The utility of liquid biopsy in clinical genetic diagnosis of cancer and monogenic mosaic disorders.液体活检在癌症和单基因嵌合性疾病临床基因诊断中的应用。
Med Genet. 2023 Dec 5;35(4):275-284. doi: 10.1515/medgen-2023-2066. eCollection 2023 Dec.
6
kmerDB: A database encompassing the set of genomic and proteomic sequence information for each species.kmer数据库:一个包含每个物种基因组和蛋白质组序列信息集合的数据库。
Comput Struct Biotechnol J. 2024 Apr 21;23:1919-1928. doi: 10.1016/j.csbj.2024.04.050. eCollection 2024 Dec.
Genome Biol. 2021 May 3;22(1):133. doi: 10.1186/s13059-021-02318-x.
4
An extended APOBEC3A mutation signature in cancer.癌症中扩展的 APOBEC3A 突变特征。
Nat Commun. 2021 Mar 11;12(1):1602. doi: 10.1038/s41467-021-21891-0.
5
Hotspots of Human Mutation.人类突变热点。
Trends Genet. 2021 Aug;37(8):717-729. doi: 10.1016/j.tig.2020.10.003. Epub 2020 Nov 13.
6
Expanded encyclopaedias of DNA elements in the human and mouse genomes.人类和小鼠基因组中 DNA 元件的扩展百科全书。
Nature. 2020 Jul;583(7818):699-710. doi: 10.1038/s41586-020-2493-4. Epub 2020 Jul 29.
7
Cancer mutational signatures representation by large-scale context embedding.大规模语境嵌入的癌症突变特征表示。
Bioinformatics. 2020 Jul 1;36(Suppl_1):i309-i316. doi: 10.1093/bioinformatics/btaa433.
8
AID Overlapping and Polη Hotspots Are Key Features of Evolutionary Variation Within the Human Antibody Heavy Chain (IGHV) Genes.AID 重叠和 Polη 热点是人类抗体重链(IGHV)基因内进化变异的关键特征。
Front Immunol. 2020 Apr 30;11:788. doi: 10.3389/fimmu.2020.00788. eCollection 2020.
9
The repertoire of mutational signatures in human cancer.人类癌症中的突变特征谱。
Nature. 2020 Feb;578(7793):94-101. doi: 10.1038/s41586-020-1943-3. Epub 2020 Feb 5.
10
Analyses of non-coding somatic drivers in 2,658 cancer whole genomes.分析 2658 个癌症全基因组中的非编码体细胞驱动因子。
Nature. 2020 Feb;578(7793):102-111. doi: 10.1038/s41586-020-1965-x. Epub 2020 Feb 5.